Literature DB >> 17383543

Regulation of immune responses and hematopoiesis by the Rap1 signal.

Nagahiro Minato1, Kohei Kometani, Masakazu Hattori.   

Abstract

Rap1 (Ras-proximity 1), a member of the Ras family of small guanine triphosphatases (GTPases), is activated by diverse extracellular stimuli. While Rap1 has been discovered originally as a potential Ras antagonist, accumulating evidence indicates that Rap1 per se mediates unique signals and exerts biological functions distinctly different from Ras. Rap1 plays a dominant role in the control of cell-cell and cell-matrix interactions by regulating the function of integrins and other adhesion molecules in various cell types. Rap1 also regulates MAP kinase (MAPK) activity in a manner highly dependent on the context of cell types. Recent studies (including gene-targeting analysis) have uncovered that the Rap1 signal is integrated crucially and unpredictably in the diverse aspects of comprehensive biological systems. This review summarizes the role of the Rap1 signal in developments and functions of the immune and hematopoietic systems as well as in malignancy. Importantly, Rap1 activation is tightly regulated in tissue cells, and dysregulations of the Rap1 signal in specific tissues result in certain disorders, including myeloproliferative disorders and leukemia, platelet dysfunction with defective hemostasis, leukocyte adhesion-deficiency syndrome, lupus-like systemic autoimmune disease, and T cell anergy. Many of these disorders resemble human diseases, and the Rap1 signal with its regulators may provide rational molecular targets for controlling certain human diseases including malignancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383543     DOI: 10.1016/S0065-2776(06)93006-5

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  13 in total

1.  Definition of molecular determinants of prostate cancer cell bone extravasation.

Authors:  Steven R Barthel; Danielle L Hays; Erika M Yazawa; Matthew Opperman; Kempland C Walley; Leonardo Nimrichter; Monica M Burdick; Bryan M Gillard; Michael T Moser; Klaus Pantel; Barbara A Foster; Kenneth J Pienta; Charles J Dimitroff
Journal:  Cancer Res       Date:  2012-11-13       Impact factor: 12.701

2.  K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis.

Authors:  Karnail Singh; Pratima Deshpande; Guangjin Li; Mingcan Yu; Sergey Pryshchep; Mary Cavanagh; Cornelia M Weyand; Jörg J Goronzy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

3.  A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.

Authors:  Teng Wang; Chun-Yi Lyu; Yue-Hua Jiang; Xue-Yan Dong; Yan Wang; Zong-Hong Li; Jin-Xin Wang; Rui-Rong Xu
Journal:  Mol Divers       Date:  2020-07-16       Impact factor: 2.943

4.  Identification of two potential immune-related biomarkers of Graves' disease based on integrated bioinformatics analyses.

Authors:  Yihan Zhang; Jia Wei; Hong Zhou; Bingxin Li; Ying Chen; Feng Qian; Jingting Liu; Xin Xie; Huanbai Xu
Journal:  Endocrine       Date:  2022-08-13       Impact factor: 3.925

5.  Dok-4 is a novel negative regulator of T cell activation.

Authors:  Audrey Gérard; Marguerite Ghiotto; Camille Fos; Geoffrey Guittard; Daniel Compagno; Anne Galy; Serge Lemay; Daniel Olive; Jacques A Nunès
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

6.  A critical role of Rap1b in B-cell trafficking and marginal zone B-cell development.

Authors:  Yuhong Chen; Mei Yu; Andrew Podd; Renren Wen; Magdalena Chrzanowska-Wodnicka; Gilbert C White; Demin Wang
Journal:  Blood       Date:  2008-03-04       Impact factor: 22.113

7.  P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib.

Authors:  Xiao-Ru Zhou; Xiao Li; Li-Ping Liao; Jie Han; Jing Huang; Jia-Cheng Li; Hong-Ru Tao; Shi-Jie Fan; Zhi-Feng Chen; Qi Li; Shi-Jie Chen; Hong Ding; Ya-Xi Yang; Bing Zhou; Hua-Liang Jiang; Kai-Xian Chen; Yuan-Yuan Zhang; Chuan-Xin Huang; Cheng Luo
Journal:  Acta Pharmacol Sin       Date:  2021-04-13       Impact factor: 6.150

8.  Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding.

Authors:  Matthias Canault; Dorsaf Ghalloussi; Charlotte Grosdidier; Marie Guinier; Claire Perret; Nadjim Chelghoum; Marine Germain; Hana Raslova; Franck Peiretti; Pierre E Morange; Noemie Saut; Xavier Pillois; Alan T Nurden; François Cambien; Anne Pierres; Timo K van den Berg; Taco W Kuijpers; Marie-Christine Alessi; David-Alexandre Tregouet
Journal:  J Exp Med       Date:  2014-06-23       Impact factor: 14.307

9.  Small GTPase Rap1 Is Essential for Mouse Development and Formation of Functional Vasculature.

Authors:  Magdalena Chrzanowska-Wodnicka; Gilbert C White; Lawrence A Quilliam; Kevin J Whitehead
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

10.  Rap signaling in normal lymphocyte development and leukemia genesis.

Authors:  Nagahiro Minato
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.